BNET Industries
- Private
Contact Information
NAICS Code Colleges, Universities, and Professional Schools: 611310
Recent Events
-
UTSA adopts Click Commerce’s research, compliance software
-
Sole Finalist Named for UTPA President Position
-
Collaboration creates 250 jobs in Richardson
-
Gophers to Play Texas at TCF Bank Stadium in 2015
-
Tech research at UT in line for $2M in funding
-
Tech receives $21.5 million bonus from state for research
-
RF Code Announces First Ever Wire-Free Liquid Detection Sensor
-
In the race to turn back the biological clock, consumers are reaching for an unproven...
-
TerraTherm, Inc.: TerraTherm Royalty Payments to The University of Texas at Austin Top $1 Million...
-
Dallas-based Rainbow Days to put on Kids University summer camp
News & Analysis
Filter by
agreement and university of texas - All News and Analysis
Castle Biosciences Signs Option Agreement for Brain Cancer Test with The University of Texas M.D. Anderson Cancer Center
- 2008-10-07
- Brain cancer test is a molecular diagnostic test developed and validated at The University of Texas M.D. Anderson Cancer Center to prospectively demonstrate responsiveness to treatment for glioblastoma multiforme GBM, the most common form of primary brain cancer - HOUSTON -- Castle Biosciences, a recently formed, rapidly growing,...
Xpention Genetics Extends Research Agreement With The University of Texas Health Science Center at San Antonio
- 2007-02-20
Xpention Genetics, Inc. (OTCBB: XPNG) has extended the Research Agreement with The University of Texas Health Science Center at San Antonio UTHSCSA through May 31, 2007. The extension will permit completion of the research activities for the project entitled "Development of the p65 Immunological Test" as well as permit the...
Callisto Announces Sponsored Laboratory Study Agreement With M. D. Anderson Cancer Center on Degrasyn Anticancer Agents.
- 2006-06-15
NEW YORK, June 15 /PRNewswire/ -- - Research Agreement to Support Biological Studies on New Tumor-Fighting Class of Drugs Callisto Pharmaceuticals, Inc. (Amex: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and other major health...
CytoGenix and the University of Texas Medical Branch at Galveston Sign Agreement for Preclinical Testing of synDNA™ H5N1 Avian Flu Vaccine Candidates
- 2006-05-16
HOUSTON -- CytoGenix, Inc. (OTCBB:CYGX) has entered into a research agreement with the University of Texas Medical Branch at Galveston for preclinical animal studies of synDNATM H5N1 vaccine. Dr. Slobodan Paessler, scientific director of the Animal Biosafety Laboratory and the Galveston National Laboratory Advanced Veterinary Services GAVS Core will be...
Callisto Announces Sponsored Research Agreement with M.D. Anderson Cancer Center to Further Development of Degrasyn Anticancer Agents; Research Agreement to Advance Potential New Tumor-Fighting Drugs
- 2006-05-10
NEW YORK -- Callisto Pharmaceuticals, Inc. (AMEX:KAL) (FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, announced today that it has executed a sponsored research agreement with the University of Texas M. D. Anderson Cancer Center to support and accelerate development of...
Cephalon ends Parkinson's study early, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas.
- 2005-05-12
M2 PRESSWIRE-12 May 2005-US Financial Network: Cephalon ends Parkinson's study early, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:12052005 City of Industry, CA -...
EDO Corp. acquires EVI Technology , U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas.
- 2005-05-12
M2 PRESSWIRE-12 May 2005-US Financial Network: EDO Corp. acquires EVI Technology , U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:12052005 City of Industry, CA...
Angiotech Pharmaceuticals to participate in Banc of America Health Care Conference 2005, U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of Texas.
- 2005-05-12
M2 PRESSWIRE-12 May 2005-US Financial Network: Angiotech Pharmaceuticals to participate in Banc of America Health Care Conference 2005, U.S. BioDefense, Inc. Announces a New Agreement for Use of Non-Marrow Stem Cell for Cardiac Regeneration Technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:12052005...
FLIR Systems elects General William W. Crouch -U.S. Army, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas.
- 2005-05-11
M2 PRESSWIRE-11 May 2005-US Financial Network: FLIR Systems elects General William W. Crouch -U.S. Army, U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of TexasC1994-2005 M2 COMMUNICATIONS LTD RDATE:11052005 City...
U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas, Forest Laboratories to buy back 25M shares.
- 2005-05-11
M2 PRESSWIRE-11 May 2005-US Financial Network: U.S. BioDefense, Inc. announces a new agreement for use of non-marrow stem cell for cardiac regeneration technology with University of Texas, Forest Laboratories to buy back 25M sharesC1994-2005 M2 COMMUNICATIONS LTD RDATE:11052005 City of Industry,...
- 1
- 2
Glass Door
| Company | Employer Rating |
| Alcoa |  |
| CBS Corp |  |
| Johnson & Johnson | |
| Costco Wholesale |  |
|
IndustryTop Rated
